Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel Hladun

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Neuro-Oncology Advances|July 16, 2020
Phase I study of vinblastine in combination with nilotinib in children, adolescents, and young adults with refractory or recurrent low-grade gliomaStephanie Vairy, Gwénaël Le Teuff, Francisco Bautista, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|March 11, 2017
[Early clinical trials in paediatric oncology in Spain: a nationwide perspective]Francisco Bautista, Soledad Gallego, Adela Cañete, et al.
Cancer Discovery|March 16, 2022
The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent MalignanciesPablo Berlanga, Gaelle Pierron, Ludovic Lacroix, et al.
Molecular Therapy. Methods & Clinical Development|September 6, 2021
Improved collection of hematopoietic stem cells and progenitors from Fanconi anemia patients for gene therapy purposesJulián Sevilla, Susana Navarro, Paula Rio, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 10, 2024
ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancerAntonio Juan-Ribelles, Francisco Bautista, Adela Cañete, et al.
Communications Biology|September 18, 2023
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumorsMaria Eugénia Marques Da Costa, Sakina Zaidi, Jean-Yves Scoazec, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2020
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortiumAlba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2025
Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC studyFernando Carceller, Francisco Bautista, Harm Van Tinteren, et al.
Nature Medicine|September 11, 2019
Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemiaPaula Río, Susana Navarro, Wei Wang, et al.
Journal of Medical Genetics|October 7, 2019
Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studiesMassimo Bogliolo, Roser Pujol, Miriam Aza-Carmona, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Neuro-Oncology Advances|July 16, 2020
Phase I study of vinblastine in combination with nilotinib in children, adolescents, and young adults with refractory or recurrent low-grade gliomaStephanie Vairy, Gwénaël Le Teuff, Francisco Bautista, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|March 11, 2017
[Early clinical trials in paediatric oncology in Spain: a nationwide perspective]Francisco Bautista, Soledad Gallego, Adela Cañete, et al.
Cancer Discovery|March 16, 2022
The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent MalignanciesPablo Berlanga, Gaelle Pierron, Ludovic Lacroix, et al.
Molecular Therapy. Methods & Clinical Development|September 6, 2021
Improved collection of hematopoietic stem cells and progenitors from Fanconi anemia patients for gene therapy purposesJulián Sevilla, Susana Navarro, Paula Rio, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 10, 2024
ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancerAntonio Juan-Ribelles, Francisco Bautista, Adela Cañete, et al.
Communications Biology|September 18, 2023
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumorsMaria Eugénia Marques Da Costa, Sakina Zaidi, Jean-Yves Scoazec, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2020
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortiumAlba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2025
Prognostic factors of early mortality in children and adolescents with relapsed/refractory solid tumors participating in dose-finding trials in the targeted and immune therapies era: An ITCC studyFernando Carceller, Francisco Bautista, Harm Van Tinteren, et al.
Nature Medicine|September 11, 2019
Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemiaPaula Río, Susana Navarro, Wei Wang, et al.
Journal of Medical Genetics|October 7, 2019
Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studiesMassimo Bogliolo, Roser Pujol, Miriam Aza-Carmona, et al.
Pageof 3